Abstract: A sexual therapy formulation for treatment of a patient suffering from erectile dysfunction as well as low or reduced libido. The formulation includes an erection enhancement component comprising one or more of sildenafil citrate, vardenafil hydrochloride, tadalafil, avanafil, and/or an alternate phosphodiesterase-5 inhibitor. The formulation also includes a libido stimulation component comprising one or more of dehydroepiandrosterone, testosterone, dihydrotestosterone, L-arginine, L-citrulline, Vitamin E, fenugreek, ginseng, maca, yohimbine, and/or 3,4-methylenedioxymethamphetamine including isomers and/or racemic mixtures thereof. A synergistic effect results from the erection enhancement component combined with the libido stimulation component allowing the patient to obtain and maintain an erection thus permitting the patient to engage in intimate sexual activity, as well providing the patient with the desire to engage in intimate sexual activity.

Abstract: A sexual therapy formulation for treatment of a patient suffering from erectile dysfunction as well as low or reduced libido. The formulation includes an erection enhancement component comprising one or more of sildenafil citrate, vardenafil hydrochloride, tadalafil, avanafil, and/or an alternate phosphodiesterase-5 inhibitor. The formulation also includes a libido stimulation component comprising one or more of dehydroepiandrosterone, testosterone, dihydrotestosterone, L-arginine, L-citrulline, Vitamin E, fenugreek, ginseng, maca, yohimbine, and/or 3,4-methylenedioxymethamphetamine including isomers and/or racemic mixtures thereof. A synergistic effect results from the erection enhancement component combined with the libido stimulation component allowing the patient to obtain and maintain an erection thus permitting the patient to engage in intimate sexual activity, as well providing the patient with the desire to engage in intimate sexual activity.